Top Story

Palivizumab prophylaxis for RSV requires more definitive data

November 22, 2014

NEW YORK — In light of the AAP’s recent recommendations on palivizumab for treatment of respiratory syncytial virus, benefits and disadvantages of the treatment were discussed during a keynote address at the 2014 Infectious Diseases in Children Symposium.

H. Cody Meissner, MD, an Infectious Diseases in Children Editorial Board member, led the discussion, touching on the overall burden of RSV among all age groups, historical background on the treatment of RSV and the AAP’s guidance regarding RSV immunoprophylaxis.

thumbnail for video 3904927585001 Meeting News CoverageVideo

Early doxycycline treatment needed to address tick-borne rickettsial disease

November 22, 2014
NEW YORK — Gordon E. Schutze, MD, professor of pediatrics and retrovirology at the Baylor College of Medicine, discusses treatment for the range of lesser-known…

CDC: Respiratory illness reports rising, enterovirus D68 cases decline

November 21, 2014
While many states are experiencing reductions in the number of new enterovirus D68-associated illnesses, the CDC recently has received data indicating that some states…

Infectious Diseases In Children Symposium to highlight advances in research, patient care

November 21, 2014
The Infectious Diseases in Children and Healio.com/Pediatrics team will present live coverage from the annual Infectious Diseases in Children Symposium, starting…
More News Headlines »
Original Article

Influences of Topical Cyclopentolate on Anterior Chamber Parameters With a Dual-Scheimpflug Analyzer in Healthy Children

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, November 19, 2014
To evaluate the changes of anterior segment parameters following the topical instillation of cyclopentolate…
More »
CME
Cover

Updates in Systemic Juvenile Idiopathic Arthritis: What New Guidelines Mean to Your Practice

This activity is supported by an educational grant from Genentech, Inc.

Systemic juvenile idiopathic arthritis (JIA) accounts for 5% to 15% of patients diagnosed with JIA and is the most…
More »
Meeting News Coverage Video
thumbnail for video 3890601030001

Treatment parameters reviewed for asthma in 'yellow zone'

November 14, 2014
ATLANTA — In this video, Chitra Dinakar, MD, FACAAI, professor of pediatrics, University of Missouri-Kansas…
More »
morganatic-roan
morganatic-roan